15 April, 2021

Observational studies with drugs published in the Spanish Trial Registry

  Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has communicated that Royal Decree 957/2020, of November 3, which regulates observational studies with […]
17 March, 2021

Spain launched 44 clinical trials for cardiovascular diseases in 2020

Pharmacological treatments, together with heart-healthy lifestyles, are the factors that contribute the most to improving the control of these pathologies The pharmaceutical industry has 600 investigational […]
11 March, 2021

Promoting the use of biomarkers improves cancer diagnosis and treatment

A new study evaluates the availability, quality and reimbursement of these tests in the European Union It proposes short and long-term measures to move towards precision […]
4 March, 2021

20% of clinical trials in Spain are already focused on rare diseases

The European Regulation on Orphan Medicines of the year 2000 has been the key in this research launch A quarter of the annual approvals of new […]
23 February, 2021

Clinical trials: this is how drugs and vaccines are designed

Medications and vaccines don’t come out of nowhere. They are not done in a rush and they are not due to commercial gimmicks. They are the […]
5 February, 2021

Cancer: the fight is not stopped by the covid; 4 out of 10 investigational drugs are antitumor

Source: https: www.diariofarma.com Cancer continues to be one of the main fronts of the fight for drug research. On the occasion of tomorrow’s World Cancer Day […]
26 January, 2021

CARTs effective for solid tumors, not just blood cancers

An American study indicates that these cells can fight breast, colon and lung cancer Source: www.redaccionmedica.com A new study, led by researchers at UT Southwestern (UTSW) […]
14 December, 2020

Why might the development of a new drug take more than 10 years?

Source: www.lne.es New drugs are responsible for 73% of the prolongation of life expectancy in developed countries and have managed to solve more and more diseases. […]
9 December, 2020

The pharmaceutical industry once again sets a record for investment in R&D in Spain

Source: www.lavozdegalicia.es The sector has registered an investment in research and development of 1,211 million euros in 2019, 5.2% more than the previous year In these […]
30 November, 2020

The Royal Decree that regulates observational studies with medicines for human use approved

Source: www.noticias.juridicas.com Royal Decree 957/2020, of November 3, establishes the conditions that must be met to proceed with the evaluation, performance and monitoring of observational studies […]
19 November, 2020

Eight drug projects of small Spanish companies attract the interest of pharmaceutical companies

New meeting of the Farma-Biotech program, which brings start-ups and research groups into contact with national and international pharmaceutical companies to promote preclinical research and facilitate […]
9 November, 2020

Regulatory alignment and mutual recognition for the manufacture of medicines, needs of the pharmaceutical industry in the face of ‘Brexit’

Pharmaceutical companies are working to ensure seamless access to medicines ahead of the UK’s exit from the EU, due in January Farmaindustria and the British Embassy […]
Private zoneHoja de Validación
Reembolso de Gastos